H-L-Cys(Acm)-OH*HCl

H-L-Cys(Acm)-OH*HCl is a chiral cysteine derivative in which the thiol side chain is protected as an acetamidomethyl (Acm) thioether, while the α-amino group and α-carboxylic acid remain available for peptide coupling after appropriate activation. The salt form with hydrochloride addresses basicity of the amino functionality, improving handling of this amino acid building block in synthesis workflows. The stereogenic center at the α-carbon preserves cysteine stereochemistry for incorporation into peptide sequences, and the protected sulfur can be selectively deprotected under controlled conditions to regenerate a reactive thiol for disulfide formation, thioether exchange, or further functionalization. The presence of the carboxylic acid and protected amine/thiol pattern makes the compound suitable as a controlled intermediate for cysteine-containing peptide construction and downstream sulfur chemistry.

1. Protected Amino Acids

H-L-Cys(Acm)-OH*HCl is used in protected amino acid synthesis and peptide-building-block preparation because the Acm group masks the cysteine thiol during coupling steps that would otherwise lead to side reactions such as oxidation or thioester formation. The α-carboxylic acid functionality supports activation to peptide-compatible derivatives, while the amino group can be managed through standard protection/deprotection logic to match the protecting-group scheme of a target sequence. The stereochemical integrity of the cysteine center enables stereodefined incorporation into growing peptide chains without racemization under appropriately designed coupling conditions. Selective Acm deprotection then provides access to a regenerated thiol for subsequent disulfide bond engineering or selective sulfur functionalization, aligning protected amino acid strategies with cysteine-specific reactivity control.

2. Peptide Synthesis

H-L-Cys(Acm)-OH*HCl serves as a cysteine-containing peptide synthesis reagent where orthogonal thiol protection is required to maintain sulfur stability throughout iterative coupling and purification. The Acm-protected side chain suppresses thiol oxidation and minimizes undesired crosslinking during standard amide bond formation, while the α-amino acid backbone participates as a chiral residue in peptide coupling chemistry. The compound's salt form supports consistent handling in automated or batch peptide workflows, and the protected sulfur can be unveiled later to enable site-selective disulfide formation or thiol-mediated conjugation. Downstream, the resulting cysteine-bearing peptides can be used to generate structured peptide analogs, conformationally constrained disulfide scaffolds, or sequence-defined intermediates for further derivatization.

3. Bioconjugation Chemistry

H-L-Cys(Acm)-OH*HCl is applied in bioconjugation chemistry and chemical biology workflows where controlled thiol availability is needed for conjugation to biomolecules or surfaces. The Acm-thiol protection pattern allows the amino acid derivative to be incorporated into peptide tags or linker segments without premature thiol reactivity, while the regenerated cysteine thiol can later participate in thiol-disulfide exchange, thioether formation, or maleimide-type coupling strategies under conditions compatible with sensitive biomolecular substrates. The preserved α-stereochemistry supports predictable incorporation into peptide-based linkers, improving reproducibility of conjugation sites relative to cysteine position. The compound therefore functions as a stereodefined, sulfur-reactive handle precursor that can be converted into labeled peptides, affinity probes, or modular conjugation intermediates for downstream biomolecule modification.

4. Peptidomimetics And SAR

H-L-Cys(Acm)-OH*HCl is used in peptidomimetic construction and structure-activity relationship studies where cysteine side-chain chemistry is leveraged to tune binding interfaces, redox stability, or conformational constraints. The Acm-protected sulfur enables the synthesis of cysteine-containing analogs without uncontrolled oxidation during scaffold assembly, while the chiral α-amino acid core supports incorporation into peptide-like frameworks and constrained turn or helix mimics. Selective thiol unveiling supports generation of disulfide-bridged analogs or thiol-reactive intermediates that can be further elaborated into thioethers, sulfoxides, or other sulfur-modified motifs used in SAR exploration. The resulting sulfur-defined peptidomimetics can then be used as chemically characterized inputs for comparative studies of structure-function relationships in medicinal chemistry and chemical biology.

5. Process Chemistry Intermediate

H-L-Cys(Acm)-OH*HCl is suitable for process chemistry intermediate preparation in fine chemical and pharmaceutical intermediate manufacturing where orthogonally protected cysteine building blocks are required to control impurity formation. The Acm thioether protection suppresses thiol oxidation and reduces the likelihood of sulfur-related byproducts during activation, coupling, and intermediate isolation steps, supporting robust synthetic handling. The hydrochloride salt form can improve reproducibility in material transfer and dosing into subsequent steps, while the defined stereocenter helps maintain stereochemical consistency across multistep sequences. Downstream, the compound can be converted into cysteine-containing intermediates for larger-scale peptide fragments, disulfide-containing constructs, or sulfur-functionalized reagents that feed into manufacturing of peptide-based research materials and specialty chemical products.

1. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

2. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

3. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

4. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

5. High fat diet and GLP-1 drugs induce pancreatic injury in mice